Clinical Trials Directory

Trials / Completed

CompletedNCT02575664

Effects of Low Dose Buprenorphine on Recovery After Hip or Knee Arthroplasty

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
160 (actual)
Sponsor
Kuopio University Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Buprenorphine is a highly lipophilic thebaine derivative that appears to have high affinity for mu-, kappa-, and delta-opioid receptors and low affinity for opioid receptors like 1 -receptors. It acts as a partial agonist at the mu-opioid and as a partial agonist/antagonist at the kappa-opioid, and as an antagonist at the delta opioid receptors. Buprenorphine has up to two-fold duration of action and it is approximately 30-fold more potent when compared to morphine. Pain is a common problem in patients coming to joint arthroplastic surgery. Buprenorphine low dose patches are recommended for treatment of moderate pain for example osteoarthritis pain. It is known that well treated pain even preoperatively may prevent prolonged postsurgical pain. In the present study the effects of low dose buprenorphine on postoperative pain and recovery were assessed.

Conditions

Interventions

TypeNameDescription
DRUGBuprenorphineBuprenorphine 5 microg/h/7 days
DRUGPlaceboPlacebo patch

Timeline

Start date
2012-08-01
Primary completion
2015-10-01
Completion
2015-10-01
First posted
2015-10-15
Last updated
2015-12-29

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT02575664. Inclusion in this directory is not an endorsement.